Becker's Healthcare September 10, 2024
Healthcare organizations, along with companies like Amazon, have written letters to Congress and the White House, urging them to ensure continued access to remote prescribing of controlled substances.
The letters, dated Sept. 10 and signed by more than 330 stakeholder organizations, were co-led by the American Telemedicine Association and ATA Action. In these letters, the organizations are asking Congress and the White House to safeguard pandemic-era flexibilities that allow for remote prescribing of controlled substances.
Specifically, the organizations are calling on House and Senate leaders to include a two-year extension of these remote prescribing flexibilities in an end-of-year legislative package. Additionally, they are urging the Biden Administration to collaborate with the Drug Enforcement Administration and other relevant agencies to use...